Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
To evaluate the efficacy of Seocalcitol in prolonging time to relapse following intended curative resection or percutaneous ablative treatment, i.e. percutaneous ethanol injection(s), percutaneous acetic acid injection(s), percutaneous microwave coagulation therapy, or percutaneous radiofrequency ablation for hepatocellular carcinoma (HCC).
Liver Neoplasms
DRUG: Seocalcitol
Time to relapse, relapse being defined as the first recurrence of HCC (intra- or extrahepatic).
Survival|Time to distant recurrence of HCC|Time to second primary HCC|Time to development of metastases|Tumour measurements|Tumour marker (alpha-fetoprotein AFP)|Quality of life|Length of hospital stay|Adverse events|Laboratory safety examinations|Dose of Seocalcitol
To evaluate the efficacy of Seocalcitol in prolonging time to relapse following intended curative resection or percutaneous ablative treatment, i.e. percutaneous ethanol injection(s), percutaneous acetic acid injection(s), percutaneous microwave coagulation therapy, or percutaneous radiofrequency ablation for hepatocellular carcinoma (HCC).